Launch of the ICPerMed Database and publication of the ICPerMed State of the Art Report 2017

19 June 2018 – The International Consortium for Personalised Medicine (ICPerMed) launched the ICPerMed mapping database on funding for research in personalised medicine, and published its first “State of the Art Report 2017”.

Launch of the “ICPerMed mapping database - funding for research in Personalised Medicine”

The ICPerMed database on funding activities for personalised medicine (PM) research has been launched. The ICPerMed database gives an overview on the actions in the field of PM performed in the ICPerMed member states and may assist interested users in finding suitable funding opportunities and information about potential funders in their respective country and/or region.

Via the ICPerMed database, ICPerMed members (e.g. funding agencies and ministries) provide available information about their national/regional funding activities in PM. The different national/regional funding schemes and general funding information are described. The database allows the user to search for programmes financing research projects in the field of PM. This includes not only programmes that are ongoing but also those that are already completed as well as others that will start in the near future. Therewith, the ICPerMed database reflects the progress of the ICPerMed consortium towards the objectives and implementation of the ICPerMed Action Plan.

The ICPerMed database is now open to the public. The access to the data requires simple registration.

Please find the ICPerMed database here

Publication of the State of the Art Report 2017

The first State of the Art Report 2017 focuses on ICPerMed activities performed in the first year since the establishment of the consortium: November 2016 to October 2017. With its annual State of the Art Reports, ICPerMed seeks to facilitate the follow-up of the development of PM research and its implementation throughout Europe and beyond. The annual reports describe the strategies and achievements ICPerMed delivers on its objectives and serves as an instrument to monitor the efforts of, and steps taken towards, the implementation of its work plan: the ICPerMed Action Plan.

Please find the ICPerMed State of the Art Report 2017 here

The International Consortium for Personalised Medicine (ICPerMed) provides a platform to initiate and support communication and exchange on personalised medicine research, funding and implementation. ICPerMed assembles over 35 European and international partners representing ministries, funding agencies and the European Commission. With the support of the ICPerMed Secretariat, the consortium works on coordinating and supporting research to develop approaches for personalised medicine. Thereby, the central aim of ICPerMed is to align and encourage joint efforts in personalised medicine research and implementation on a European and international level. These activities are closely linked to the ICPerMed Action Plan, published in March 2017.
More information on ICPerMed can be found on the ICPerMed website: www.icpermed.eu